세계의 표적 시퀀싱 및 재시퀀싱 시장

Global Targeted Sequencing and Resequencing Market to Reach US$22.8 Billion by 2030

The global market for Targeted Sequencing and Resequencing estimated at US$7.4 Billion in the year 2024, is expected to reach US$22.8 Billion by 2030, growing at a CAGR of 20.6% over the analysis period 2024-2030. Sequencing, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$15.8 Billion by the end of the analysis period. Growth in the Re-Sequencing segment is estimated at 16.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 28.0% CAGR

The Targeted Sequencing and Resequencing market in the U.S. is estimated at US$2.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.5 Billion by the year 2030 trailing a CAGR of 28.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.2% and 18.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.3% CAGR.

Global Targeted Sequencing and Resequencing Market - Key Trends & Drivers Summarized

Why Are Researchers and Clinicians Prioritizing Targeted Sequencing Over Broader Genomic Approaches?

Targeted sequencing and resequencing are gaining widespread adoption as powerful alternatives to whole-genome and transcriptome sequencing due to their ability to focus on specific genomic regions of interest with exceptional accuracy, efficiency, and cost-effectiveness. Unlike whole-genome approaches, which require significant data processing, storage, and interpretation of vast amounts of non-essential information, targeted sequencing enables scientists to zero in on known disease-associated genes, hotspots, or mutations-yielding clinically actionable results faster and with less computational burden. This precision-driven strategy is especially valuable in diagnostics, where time-sensitive and cost-sensitive tests are needed to inform therapeutic decision-making, such as in oncology, rare disease screening, and pharmacogenomics. Targeted resequencing, in particular, plays a vital role in studying genomic variability among individuals or populations by focusing on previously identified loci, making it an essential tool for population genetics, evolutionary biology, and mutational studies. These approaches also offer deep coverage of selected regions, enabling the detection of low-frequency variants that might be missed with broader sequencing. The flexibility to customize gene panels, the compatibility with degraded samples such as FFPE tissues, and the streamlined data interpretation workflows are further contributing to the increasing reliance on targeted strategies. As the healthcare sector moves toward personalized and precision medicine models, targeted sequencing and resequencing are providing the granularity, scalability, and relevance that researchers and clinicians need to drive impactful discoveries and informed clinical decisions.

How Are Advancements in Technology Enhancing the Capabilities of Targeted Sequencing?

The rapid evolution of sequencing technologies, library preparation kits, and bioinformatics pipelines is significantly enhancing the accuracy, speed, and flexibility of targeted sequencing and resequencing workflows. Next-generation sequencing (NGS) platforms now offer ultra-deep sequencing capabilities with higher throughput, lower error rates, and shorter run times, allowing researchers to interrogate specific genomic regions at single-nucleotide resolution. Hybrid capture and amplicon-based enrichment techniques are becoming more refined, offering high specificity and minimal off-target noise, even in low-input or damaged samples. Improvements in probe design, indexing, and barcoding are enabling the multiplexing of hundreds of samples in a single run without compromising data quality. Emerging long-read technologies are complementing short-read methods, allowing for better resolution of structural variants, repeat regions, and complex genomic rearrangements in targeted regions. Automated workflows and liquid-handling robotics are improving reproducibility and minimizing human error, which is particularly valuable in clinical and high-throughput research labs. On the data analysis side, machine learning algorithms and AI-powered annotation platforms are transforming variant calling, interpretation, and visualization-making it easier to identify clinically relevant mutations and prioritize actionable results. Cloud-based storage and analysis solutions are also becoming more integrated, enabling real-time collaboration, regulatory compliance, and efficient data sharing across research institutions. Additionally, targeted panels are being tailored for specific disease applications, including oncology, cardiogenetics, neurogenetics, and infectious diseases, providing fit-for-purpose diagnostic and research tools. These technological strides are expanding the versatility of targeted sequencing, ensuring it remains a foundational technique in both research and clinical genomics.

Where Is Targeted Sequencing and Resequencing Being Applied, and How Are Use Cases Evolving?

The applications of targeted sequencing and resequencing span a growing array of disciplines, from clinical diagnostics and pharmacogenomics to agricultural genomics and evolutionary biology. In healthcare, targeted sequencing panels are being widely used in oncology to identify driver mutations, guide targeted therapies, and monitor treatment resistance. Liquid biopsy-based tests using targeted panels are gaining traction for non-invasive cancer monitoring and minimal residual disease detection. In rare disease diagnosis, especially for genetically heterogeneous conditions, targeted resequencing enables clinicians to focus on curated sets of genes to improve diagnostic yield while keeping costs manageable. Infectious disease specialists use targeted sequencing to monitor pathogen evolution, resistance gene spread, and outbreak tracking. In pharmacogenomics, panels targeting drug metabolism genes are used to predict patient responses and personalize therapy plans. Beyond human health, plant and animal breeders use targeted sequencing to identify and track desirable traits, support marker-assisted selection, and protect biodiversity. In microbial ecology, researchers use targeted resequencing of specific 16S, 18S, or ITS regions to profile complex communities and study microbial interactions. Population geneticists use targeted resequencing to study ancestral lineages, disease predisposition, and gene-environment interactions across different cohorts. The utility of targeted approaches is also expanding in forensics, where customized panels are used for identity verification, kinship analysis, and mixture resolution. As regulatory standards evolve and NGS becomes more embedded in routine practice, targeted sequencing and resequencing are becoming go-to solutions for laboratories and organizations aiming to maximize scientific yield while minimizing costs and complexity.

What’s Fueling the Global Growth of the Targeted Sequencing and Resequencing Market?

The global market for targeted sequencing and resequencing is being propelled by a combination of rising demand for precision medicine, improvements in sequencing technology, the growing burden of chronic and genetic diseases, and the need for cost-effective genomic solutions. Healthcare systems worldwide are prioritizing rapid, accurate, and clinically relevant diagnostics, which targeted panels are uniquely positioned to deliver. The rising incidence of cancer, rare disorders, and infectious disease outbreaks is pushing demand for fast, high-confidence testing that can guide treatment and containment strategies. Regulatory approvals of panel-based diagnostics and increasing reimbursement support are encouraging clinical adoption across major markets. In the research sector, expanding government and private investment in genomics is supporting the use of targeted methods for high-impact projects, such as biobanking, large cohort studies, and precision agriculture initiatives. The emergence of turnkey sequencing solutions-complete with pre-validated panels, automated prep kits, and integrated analysis software-is lowering the barrier to entry for smaller labs and decentralized facilities. Academic-industrial partnerships are accelerating innovation in disease-specific panel development, ensuring a steady pipeline of relevant solutions tailored to emerging clinical and research needs. Additionally, as global emphasis on data security and compliance grows, cloud-based platforms and secure data pipelines are making it easier to deploy targeted sequencing in regulated environments. The scalability, affordability, and growing range of applications for targeted sequencing and resequencing ensure that this market will continue expanding rapidly-anchored in its ability to deliver focused, high-value genomic insights across disciplines.

SCOPE OF STUDY:

The report analyzes the Targeted Sequencing and Resequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Sequencing, Re-Sequencing); Type (DNA-based targeted sequencing, RNA-based targeted sequencing); Application (Clinical application, Plant & animal sciences, Drug development, Others); End-Use (Hospitals & Clinics, Academic research, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Agilent Technologies, Inc.
• Azenta Life Sciences (GENEWIZ)
• BGI Genomics
• Bio-Rad Laboratories, Inc.
• CD Genomics
• CosmosID
• DNASTAR, Inc.
• Element Biosciences
• Eurofins Genomics
• F. Hoffmann-La Roche Ltd
• GATC Biotech AG
• Genomatix GmbH
• Illumina, Inc.
• Integrated DNA Technologies, Inc.
• Macrogen, Inc.
• New England Biolabs
• Novogene Corporation
• Oxford Nanopore Technologies plc
• Pacific Biosciences of California, Inc.
• Paragon Genomics
• PerkinElmer, Inc.
• PierianDx

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Targeted Sequencing and Resequencing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Demand for Focused Genomic Insights Throws the Spotlight on Targeted Sequencing and Resequencing in Clinical and Research Applications
  • Rising Adoption of Precision Medicine Propels Utilization of Disease-Specific Gene Panels for Targeted Genetic Analysis
  • Need for Cost-Effective and Scalable Sequencing Solutions Strengthens the Business Case for Targeted Approaches Over Whole Genome Methods
  • Expansion of Rare Disease Diagnostics and Carrier Screening Drives Growth in Customizable Resequencing Panels
  • Integration with Liquid Biopsy and Minimal Residual Disease Testing Accelerates Use of Targeted Assays in Oncology
  • Technological Advancements in Library Preparation and Target Enrichment Enhance Efficiency and Coverage Depth
  • Increasing Application in Infectious Disease Surveillance Expands the Addressable Market for Targeted RNA Sequencing
  • Wider Adoption of Pharmacogenomics Testing Drives Routine Use of Targeted Sequencing in Personalized Therapy Selection
  • Cloud-Based Data Analysis and Bioinformatics Tools Streamline Workflow Integration for Clinical and Research Labs
  • Academic and Translational Research Initiatives Sustain Demand for Targeted Resequencing in Population and Cohort Studies
  • Emergence of Multi-Omic and Single-Cell Platforms Drives Incorporation of Targeted Genomics in Systems Biology Research
  • Global Expansion of Genomic Biobanks and Precision Health Initiatives Fuels High-Throughput Demand for Targeted Resequencing Applications
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Targeted Sequencing and Resequencing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Targeted Sequencing and Resequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Targeted Sequencing and Resequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Re-Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Re-Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Re-Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for DNA-based targeted sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for DNA-based targeted sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for DNA-based targeted sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for RNA-based targeted sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for RNA-based targeted sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for RNA-based targeted sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Clinical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Clinical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Plant & Animal Sciences by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Plant & Animal Sciences by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Plant & Animal Sciences by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Targeted Sequencing and Resequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 101: France Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 137: UK Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 212: India Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Targeted Sequencing and Resequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Targeted Sequencing and Resequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION